234 related articles for article (PubMed ID: 22659593)
41. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
Hiraga T; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 2001 Jun; 61(11):4418-24. PubMed ID: 11389070
[TBL] [Abstract][Full Text] [Related]
42. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.
Wang JW; Zheng W; Liu JB; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
PLoS One; 2013; 8(3):e58274. PubMed ID: 23469274
[TBL] [Abstract][Full Text] [Related]
43. Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts.
Arteaga-Marrero N; Rygh CB; Mainou-Gomez JF; Nylund K; Roehrich D; Heggdal J; Matulaniec P; Gilja OH; Reed RK; Svensson L; Lutay N; Olsen DR
Contrast Media Mol Imaging; 2015; 10(6):428-37. PubMed ID: 26010530
[TBL] [Abstract][Full Text] [Related]
44. Comparison of consecutive bolus tracking and flash replenishment measurements for the assessment of tissue hemodynamics using contrast-enhanced ultrasound (CEUS) in an experimental human squamous cell carcinoma model.
Paprottka PM; Ingrisch M; Koelln A; Zengel P; Cyran CC; Nikolaou K; Reiser MF; Clevert DA
Clin Hemorheol Microcirc; 2012; 52(2-4):107-14. PubMed ID: 22960296
[TBL] [Abstract][Full Text] [Related]
45. Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy.
Mahéo K; Chevalier S; Vibet S; Bougnoux P; Richard S; Serrière S; Bleuzen A; Tranquart F; Goupille C
Breast Cancer Res Treat; 2012 Aug; 134(3):1013-25. PubMed ID: 22438047
[TBL] [Abstract][Full Text] [Related]
46. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D
Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292
[TBL] [Abstract][Full Text] [Related]
47. Dynamic contrast-enhanced MRI for monitoring antiangiogenic treatment: determination of accurate and reliable perfusion parameters in a longitudinal study of a mouse xenograft model.
Song Y; Cho G; Suh JY; Lee CK; Kim YR; Kim YJ; Kim JK
Korean J Radiol; 2013; 14(4):589-96. PubMed ID: 23901316
[TBL] [Abstract][Full Text] [Related]
48. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
49. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
51. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.
Peyruchaud O; Winding B; Pécheur I; Serre CM; Delmas P; Clézardin P
J Bone Miner Res; 2001 Nov; 16(11):2027-34. PubMed ID: 11697798
[TBL] [Abstract][Full Text] [Related]
52. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.
Klotz LV; Clevert DA; Scheckinger S; Strieth S; Eichhorn ME
Anticancer Res; 2015 May; 35(5):2571-6. PubMed ID: 25964532
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
54. The effect of Neovastat (AE-941) on an experimental metastatic bone tumor model.
Weber MH; Lee J; Orr FW
Int J Oncol; 2002 Feb; 20(2):299-303. PubMed ID: 11788892
[TBL] [Abstract][Full Text] [Related]
55. Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein.
Bäuerle T; Adwan H; Kiessling F; Hilbig H; Armbruster FP; Berger MR
Int J Cancer; 2005 Jun; 115(2):177-86. PubMed ID: 15688393
[TBL] [Abstract][Full Text] [Related]
56. Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model.
Yang C; Lee DH; Mangraviti A; Su L; Zhang K; Zhang Y; Zhang B; Li W; Tyler B; Wong J; Wang KK; Velarde E; Zhou J; Ding K
Med Phys; 2015 Aug; 42(8):4762-72. PubMed ID: 26233204
[TBL] [Abstract][Full Text] [Related]
57. Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.
Neudert M; Fischer C; Krempien B; Bauss F; Seibel MJ
Int J Cancer; 2003 Nov; 107(3):468-77. PubMed ID: 14506749
[TBL] [Abstract][Full Text] [Related]
58. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
[TBL] [Abstract][Full Text] [Related]
60. Tumor Blood Vessel Visualization.
Gillmann C; Bäuerle T
Methods Mol Biol; 2016; 1464():163-173. PubMed ID: 27858365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
